logo
Plus   Neg
Share
Email

Microsoft Results Beat Street View Driven By Strong Azure Growth

Software giant Microsoft Corp. (MSFT), Wednesday reported a profit and revenue for the first quarter that beat Wall Street analysts' estimates driven by growth in cloud business.

Redmond, Washington-based Microsoft reported first-quarter profit of $10.68 billion or $1.38 per share, up from last year's profit of $8.82 billion or $1.14 per share. On average, 29 analysts polled by Thomson Reuters expected earnings of $1.24 per share for the quarter.

Revenues for the quarter grew 14 percent to $33.06 billion from $29.08 billion last year. Analysts had a consensus revenue estimate of $32.23 billion for the quarter.

"It was a strong start to the fiscal year with our commercial cloud generating $11.6 billion in revenue for the quarter, up 36% year over year," said Amy Hood, executive vice president and chief financial officer of Microsoft.

Intelligent Cloud segment revenues, which includes its Azure on-demand computing services, increased 27 percent to $10.8 billion, with Azure revenues surging 59 percent.

Revenues in Productivity and Business Processes rose 13 percent to $11.1 billion, with office commercial products and cloud services revenue up 13 percent driven by Office 365 commercial revenue growth of 25 percent.

Revenues in More Personal Computing segment, which includes Windows operating system, increased 4 percent to $11.1 billion.

MSFT closed Wednesday's trading at $137.24, up $0.87 or 0.64%, on the Nasdaq. The stock, however, dropped $0.69 or 0.50% in the after-hours trade.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Golden Pearl Trading Corp. is recalling certain ready-to-eat or RTE imported Siluriformes products that were produced without benefit of import inspection, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. The recall involves around 12,054 pounds of Siluriformes products that were not presented for import re-inspection into the United States. The U.S. Food and Drug Administration has granted accelerated approval to Tazverik for the treatment of adults and pediatric patients aged 16 years and older with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection. Epithelioid sarcoma is a rare sub-type of soft... STIHL recalls about 16,400 STIHL RE 90 pressure washers due to injury hazard. According to the company, the recalled pressure washer nozzle can disconnect from the spray wand when under pressure during use, posing an injury hazard. STIHL said it received seven reports of the nozzle detaching from...
Follow RTT
>